| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.0009 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |